Jianming Pei

8.2k total citations · 1 hit paper
184 papers, 4.2k citations indexed

About

Jianming Pei is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Jianming Pei has authored 184 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Molecular Biology, 51 papers in Pulmonary and Respiratory Medicine and 47 papers in Pathology and Forensic Medicine. Recurrent topics in Jianming Pei's work include Cardiac Ischemia and Reperfusion (37 papers), Cardiac electrophysiology and arrhythmias (19 papers) and Cancer Genomics and Diagnostics (16 papers). Jianming Pei is often cited by papers focused on Cardiac Ischemia and Reperfusion (37 papers), Cardiac electrophysiology and arrhythmias (19 papers) and Cancer Genomics and Diagnostics (16 papers). Jianming Pei collaborates with scholars based in China, United States and Russia. Jianming Pei's co-authors include Joseph R. Testa, Mitchell Cheung, Yinfei Tan, Eleonora Sementino, Yuemin Wang, Michele Carbone, Harvey I. Pass, Shumiao Zhang, Tak‐Ming Wong and Juan Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Jianming Pei

175 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Germline BAP1 mutations predispose to malignant mesothelioma

2011 719 citations Joseph R. Testa, Mitchell Cheung et al. profile →

Peers

Countries citing papers authored by Jianming Pei

Since Specialization

Citations

This map shows the geographic impact of Jianming Pei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianming Pei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianming Pei more than expected).

Fields of papers citing papers by Jianming Pei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianming Pei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianming Pei. The network helps show where Jianming Pei may publish in the future.

Co-authorship network of co-authors of Jianming Pei

This figure shows the co-authorship network connecting the top 25 collaborators of Jianming Pei. A scholar is included among the top collaborators of Jianming Pei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianming Pei. Jianming Pei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Acute myeloid leukemia with a novel AKAP9::PDGFRA fusion transformed from essential thrombocythemia: A case report and mini review 2024 ·Leukemia Research Reports ·Yavuz Şahin, Jianming Pei, Don A. Baldwin, (unknown), (unknown), (unknown), Y. Lynn Wang, Reza Nejati, Joseph R. Testa	0
2	Angiotensin 1–7 increases cardiac tolerance to ischemia/reperfusion and mitigates adverse remodeling of the heart—The signaling mechanism 2024 ·Fundamental and Clinical Pharmacology ·(unknown), С. В. Попов, Л. Н. Маслов, А. V. Mukhomedzyanov, N. V. Naryzhnaya, (unknown), (unknown), А. В. Крылатов, Yu. K. Podoksenov, (unknown), (unknown), Feng Fu, Jianming Pei	5
3	Novel roles of κ-opioid receptor in myocardial ischemia-reperfusion injury 2024 ·PeerJ ·Wen Zhang, (unknown), Yali Liu, Jianming Pei, Na Feng	2
4	Ischemia/reperfusion-induced MiD51 upregulation recruits Drp1 to mitochondria and contributes to myocardial injury 2023 ·Biochemical and Biophysical Research Communications ·Tian Gao, Rui Shi, Zhenhua Liu, (unknown), Runjing Li, Yunan Chen, Jianming Pei, Mingge Ding	3
5	Molecular Characterization of TFE3-Rearranged Renal Cell Carcinoma: A Comparative Study With Papillary and Clear Cell Renal Cell Carcinomas 2023 ·Modern Pathology ·Shuanzeng Wei, (unknown), Daniel M. Geynisman, Andrew Elliott, Alexander Kutikov, Robert G. Uzzo, Jianming Pei, Pedro C. Barata, Benedito A. Carneiro, Elisabeth I. Heath, Charles J. Ryan, Alex Farrell, Chadi Nabhan, Rouba Ali‐Fehmi, Abdul Rafeh Naqash, Pedram Argani, Rana R. McKay	7
6	A historical literature review of coronary microvascular obstruction and intra-myocardial hemorrhage as functional/structural phenomena 2023 ·Journal of Biomedical Research ·Л. Н. Маслов, N. V. Naryzhnaya, С. В. Попов, А. V. Mukhomedzyanov, (unknown), (unknown), А. В. Крылатов, Feng Fu, Jianming Pei, V. V. Ryabov, (unknown), (unknown), A Boshchenko, Akpay Sarybaev	8
7	Multiple Genomic Alterations, Including a Novel AFF4::IRF1 Fusion Gene, in a Treatment-Refractory Blastic Plasmacytoid Dendritic-Cell Neoplasm: A Case Report and Literature Review 2023 ·International Journal of Molecular Sciences ·Yavuz Şahin, Y. Lynn Wang, Jianming Pei, (unknown), Michael Styler, Joseph R. Testa, Reza Nejati	3
8	Genomic Evolution of Oligometastatic Clear Cell Renal Cell Carcinoma Presenting Two Decades Following Radical Nephrectomy 2023 ·Urology ·(unknown), (unknown), Raju Chelluri, (unknown), Hormoz Ehya, Jianming Pei, Don A. Baldwin, Mariusz A. Wasik, Shuanzeng Wei, Robert G. Uzzo	0
9	K_ATP channels are regulators of programmed cell death and targets for the creation of novel drugs against ischemia/reperfusion cardiac injury 2023 ·Fundamental and Clinical Pharmacology ·Л. Н. Маслов, С. В. Попов, N. V. Naryzhnaya, А. V. Mukhomedzyanov, (unknown), (unknown), A Boshchenko, N. Rajendra Prasad, Huijie Ma, Yi Zhang, Г. З. Суфианова, Feng Fu, Jianming Pei	15
10	Genetic Variants and Tumor Immune Microenvironment: Clues for Targeted Therapies in Inflammatory Breast Cancer (IBC) 2021 ·International Journal of Molecular Sciences ·Yulan Gong, (unknown), Maria F. Arisi, Lorenzo Gerratana, (unknown), Michael Slifker, Jianming Pei, Kathy Q. Cai, (unknown), Elias Obeid, (unknown), Christopher Sebastiano, Eric A. Ross, Katherine Alpaugh, Massimo Cristofanilli, Sandra V. Fernandez	1
11	Activation of κ-opioid receptor inhibits inflammatory response induced by sodium palmitate in human umbilical vein endothelial cells 2021 ·Cytokine ·Shumiao Zhang, Fan Yang, Rui Shi, Chaoyang Liu, Lei Zhao, Xiaoming Gu, (unknown), Feng Fu, Na Feng, Yali Liu, Min Jia, Rong Fan, Lu Yang, Jun Li, (unknown), (unknown), Jianming Pei	3
12	Genetic Variants Detected Using Cell-Free DNA from Blood and Tumor Samples in Patients with Inflammatory Breast Cancer 2020 ·International Journal of Molecular Sciences ·(unknown), (unknown), Michael Slifker, Jianming Pei, (unknown), Jacqueline Talarchek, Elias Obeid, Donald Baldwin, Yulan Gong, Eric A. Ross, Massimo Cristofanilli, R. Katherine Alpaugh, Sandra V. Fernandez	12
13	Monosomy of Chromosome 9 Is Associated With Higher Grade, Advanced Stage, and Adverse Outcome in Clear-cell Renal Cell Carcinoma 2019 ·Clinical Genitourinary Cancer ·Reza Nejati, Shuanzeng Wei, Robert G. Uzzo, (unknown), Jianming Pei, Jacqueline Talarchek, Karen Ruth, Essel Dulaimi, Alexander Kutikov, Joseph R. Testa, Tahseen Al‐Saleem	4
14	Bap1 Is a Bona Fide Tumor Suppressor: Genetic Evidence from Mouse Models Carrying Heterozygous Germline Bap1 Mutations 2016 ·Cancer Research ·Yuwaraj Kadariya, Mitchell Cheung, Jinfei Xu, Jianming Pei, Eleonora Sementino, Craig W. Menges, Kathy Q. Cai, Frank J. Rauscher, Andres J. Klein–Szanto, Joseph R. Testa	79
15	Germline Mutation of Bap1 Accelerates Development of Asbestos-Induced Malignant Mesothelioma 2014 ·Cancer Research ·Jinfei Xu, Yuwaraj Kadariya, Mitchell Cheung, Jianming Pei, Jacqueline Talarchek, Eleonora Sementino, Yinfei Tan, Craig W. Menges, Kathy Q. Cai, Samuel Litwin, Hongzhuang Peng, Jayashree Karar, Frank J. Rauscher, Joseph R. Testa	107
16	NF-κB Inhibition by Bortezomib Permits IFN-γ–Activated RIP1 Kinase–Dependent Necrosis in Renal Cell Carcinoma 2013 ·Molecular Cancer Therapeutics ·Roshan J. Thapa, Peirong Chen, Mitchell Cheung, Shoko Nogusa, Jianming Pei, Suraj Peri, Joseph R. Testa, Siddharth Balachandran	19
17	Upregulation of DLX5 Promotes Ovarian Cancer Cell Proliferation by Enhancing IRS-2-AKT Signaling 2010 ·Cancer Research ·Yinfei Tan, Mitchell Cheung, Jianming Pei, Craig W. Menges, Andrew K. Godwin, Joseph R. Testa	51
18	Age-dependent mobilization of circulating endothelial progenitor cells in infants and young children undergoing cardiac surgery with cardiopulmonary bypass 2009 ·Cytokine ·(unknown), Dinghua Yi, (unknown), (unknown), (unknown), Jing Wang, Yang Liu, Jun Ren, Yuemin Wang, Shumiao Zhang, Chunhu Gu, Jianming Pei	4
19	High‐resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays 2003 ·Genes Chromosomes and Cancer ·Jeremy A. Squire, Jianming Pei, Paula Marrano, Ben Beheshti, Jane Bayani, Gloria Lim, (unknown), Maria Zieleńska	126
20	κ-Opioid Receptor Agonist Inhibits the Cholera Toxin-Sensitive G Protein in the Heart 2001 ·Journal of Cardiovascular Pharmacology ·Xiao-Chun Yu, (unknown), Jianming Pei, Weimin Zhang, Nai-Sum Wong, Tak Ming Wong	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact